The Effect of ACE Inhibitors/ARBs Withdrawal on the Risk of Postoperative Complications in Abdominal Surgery

A significant proportion of patients undergoing non-cardiac surgery receive therapy with angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs), which are usually prescribed for treatment of arterial hypertension and CHF. Current guidelines fail to provide clear consensus on whether it is worth discontinuing ACEi/ARBs before non-cardiac surgery. 

The aim of this research was to assess the contribution of pre-op ACEi/ARBs withdrawal to the development of postoperative complications in patients after abdominal surgery using data from STOPRISK database.

Materials and methods. Data of 1945 patients from of the STOPRISK database was used for the analysis. Patients were retrospectively divided into two groups: first group (N=471, 24.2%) included patients subjected to ACEi/ARBs withdrawal 24 hours before surgery, second group (N=1474, 75.8%) included patients continuing on ACEi/ARBs therapy. The 30-day outcomes were analyzed — postoperative complications (acute kidney injury, acute respiratory distress syndrome, anastomosis failure, arrhythmias, circulatory arrest, cardiogenic pulmonary edema, postoperative delirium, myocardial infarction, pneumonia, ileus, postoperative bleeding, pulmonary embolism, acute cerebrovascular accident, wound infection) and mortality. We were not evaluating intraoperative and postoperative arterial hypotension and hypertension, we analyzed the use of vasopressors as a surrogate marker. ACEi/ARBs re-initiation after surgery was not evaluated.

Results. One or more post-operative complications were documented in 113 patients (5.8%). Only postoperative delirium was more common in patients (1.06% vs. 0.27%, P=0.027) after ACEi/ARBs withdrawal 24 hours before surgery, the difference reached statistical significance. 

Sub-analysis in the group of patients with arterial hypertension as the only comorbidity showed no statistically significant differences in the outcomes. Sub-analysis in the group of patients with CFH showed higher incidence of postoperative delirium after ACEi/ARBs withdrawal (2.68% vs. 0.6%, P=0.023). The logistic regression analysis showed that the risk of developing postoperative delirium is influenced by age, vasopressor support, and ACEi/ARBs withdrawal (the area under the curve for the model was 0.92 (0.90–0.93).

Conclusion. Rates of pre-op ACEi/ARBs withdrawal (24.2%) are consistent with published data. In the entire cohort, ACEi/ARBs withdrawal resulted in higher incidence of postoperative delirium, as well as in the subgroup of patients with CHF, while ACEi/ARBs withdrawal in the subgroup of patients with arterial hypertension had no influence on postop complications.

ACEi/ARBs withdrawal, along with hemodynamic instability and older age, contributes to the development of postoperative delirium, which is the subject of future research.

1. International Surgical Outcomes Study group. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016; 117(5): 601-609. DOI: 10.1093/bja/aew316. PMID: 27799174

2. Kim M, Wall M.M., Li G. Risk stratification for major postoperative complications in patients undergoing intra-abdominal general surgery using latent class analysis. Anesth Analg. 2018; 126(3): 848–57. DOI: 10.1213/ANE.0000000000002345. PMID: 28806210

3. Roshanov P.S., Rochwerg B., Patel A., Salehian O., Duceppe E., Belley-Côté E.P., Guyatt G.H., et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort. Anesthesiology. 2017;126(1):16–27. DOI: 10.1097/ALN.0000000000001404. PMID: 27775997

4. Zabolotskikh I.B., Potievskaya V.I., Bautin A.E., Grigor'ev E.V., Grigoryev S.V., Gritsan A.I., Kirov M.Yu., et al. Perioperative management of patients with coronary artery disease. Russian Journal of Anaesthesiology and Reanimatology/ Anesteziologiya i Reanimatologiya. 2020; (3): 5-16. (In Russ.) DOI:10.17116/anaesthesiology20200315

5. Zabolotskikh IB, Bautin AE, Zamyatin MN, Lebedinskii KM, Potievskaya VI, Trembach NV. Perioperative management of patients with heart failure. Russian Journal of Anaesthesiology and Reanimatology/ Anesteziologiya i Reanimatologiya. 2021;(3):6-27. (In Russ.) DOI:10.17116/anaesthesiology20210316.

6. Kozlov I.A., Sokolov D.A. Assessment of the myocardial stress biomarker NT-proBNP in real clinical practice. General Reanimatology/Obshchaya Reanimatologya. 2023; 19(1): 4-12. (In Russ.) DOI:10.15360/1813-9779-2023-1-2272.

7. Rosenman D.J., McDonald F.S., Ebbert J.O., Erwin P.J., LaBella M., Montori V.M. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med. 2008; 3(4): 319–325. DOI: 10.1002/jhm.323. PMID: 18698608

8. Hollmann C., Fernandes N.L., Biccard B.M. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth Analg. 2018; 127(3): 678–687. DOI: 10.1213/ANE.0000000000002837. PMID: 29381513

9. Yoon U., Setren A., Chen A., Nguyen T., Torjman M., Kennedy T. Continuation of angiotensin-converting enzyme inhibitors on the day of surgery is not associated with increased risk of hypotension upon induction of general anesthesia in elective noncardiac surgeries. J Cardiothorac Vasc Anesth. 2021; 35(2): 508-513. DOI: 10.1053/j.jvca.2020.01.005. PMID: 32029371.

10. Lee S.M., Takemoto S., Wallace A.W. Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System. Anesthesiology. 2015; 123(2): 288–306. DOI: 10.1097/ALN.0000000000000739. PMID: 26200181

11. Ereso A.Q., Ramirez R.M., Sadjadi J., Cripps M.W., Cureton E.L., Curran B., Victorino G.P. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak. J Am Coll Surg. 2007; 205(4): 527–533. DOI: 10.1016/j.jamcollsurg.2007.07.026. PMID: 17903725

12. Gromotowicz-Poplawska A., Stankiewicz A., Kramkowski K., Gradzka A., Wojewodzka-Zelezniakowicz M., Dzieciol J., Szemraj J., et al. The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1. Thromb Res. 2016; 138: 114–120. DOI: 10.1016/j.thromres.2015.12.008. PMID: 26709040

13. Da Silva A.R., Fraga-Silva R..A, Stergiopulos N., Montecucco F., Mach F. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. Eur J Clin Investig. 2015; 45(3): 274–287. DOI: 10.1111/eci.12401. PMID: 25586671

14. Zabolotskikh I.B., Trembach N.V., Musaeva T.S., Dunts P.V., Golubtsov B.B., Grigoriev E.V., Gritsan A.I., et al. National multicenter prospective observational study “The role of concomitant diseases in postoperative complications risk stratification — STOPRISK”: study protocol. Ann Crit Care /Vestnik Intensivnoy Terapii im AI Saltanova. 2022; (4): 24–35. (in Russ.) DOI:10.21320/1818-474X-2022-4-24-35

15. Jammer I., Wickboldt N., Sander M., Smith A., Schultz M.J., Pelosi P., Leva B., et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015; 32(2): 88–105. DOI: 10.1097/EJA.0000000000000118. PMID: 25058504

16. Farag E., Liang L., Mascha E.J., Argalious M.Y., Ezell J., Maheshwari K., Esa W.A.S., et al. Association between use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and postoperative delirium. Anesthesiology 2020; 133(1):119–132. DOI: 10.1097/ALN.0000000000003329. PMID: 32349070

17. Farag E, Sessler D.I., Ebrahim Z., Kurz A., Morgan J., Ahuja S., Maheshwari K., et al. The renin angiotensin system and the brain: new developments. J Clin Neurosci 2017; 46:1–8. DOI: 10.1016/j.jocn.2017.08.055. PMID: 28890045

18. Ohrui T., Tomita N., Sato-Nakagawa T., Matsui T., Maruyama M., Niwa K., Arai H., et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology. 2004; 63(7):1324–5. DOI: 10.1212/01.wnl.0000140705.23869.e9. PMID: 15477567

19. Carson J.A., Turner A.J. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem. 2002; 81(1):1–8. DOI: 10.1046/j.1471-4159.2002.00855.x. PMID: 12067222

20. Mogi M., Li J.M., Iwanami J., Min L.J., Tsukuda K., Iwai M., Horiuchi M. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006; 48(1):141–8. DOI: 10.1161/01.HYP.0000229648.67883.f9. PMID: 16769992

21. Cassis P., Conti S., Remuzzi G., Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch. 2010; 459(2):325–32. DOI: 10.1007/s00424-009-0725-4. PMID: 19763608

22. Labandeira-Garcia J.L., Rodríguez-Perez A.I., Garrido-Gil P., Rodriguez-Pallares J., Lanciego J.L., Guerra M.J. Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci. 2017; 9:129. DOI: 10.3389/fnagi.2017.00129. PMID: 28515690

23. Xu Yuan, Xu Yazhoi., Wang Yurong, Wang Yunjie, He L., Jiang Z., Huang Z., et al. Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKβ-dependent AMPK activation. Brain Behav Immun. 2015; 50:298–313.25-27. DOI: 10.1016/j.bbi.2015.07.015. PMID: 26188187

24. Fogari R., Mugellini A., Zoppi A., Derosa G., Pasotti C., Fogari E., Preti P. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens. 2003; 17(11):781–5. DOI: 10.1038/sj.jhh.1001613. PMID: 14578918

25. Tedesco M.A., Ratti G., Mennella S., Manzo G., Grieco M., Rainone A.C., Iarussi D., et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens. 1999; 12(11 Pt 1):1130–4. DOI: 10.1016/s0895-7061(99)00156-9. PMID: 10604491

26. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L, Seike T., Ifuku M.. et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 2007; 101(2): 397-410. DOI:10.1111/j.1471-4159.2006.04339.x. PMID: 17402969

27. Bramley P., McArthur K., Blayney A., McCullagh I. Risk factors for postoperative delirium: an umbrella review of systematic reviews. Int J Surg. 2021; 93:106063. DOI:10.1016/j.ijsu.2021.106063. PMID: 34411752

28. Jiang X., Chen D., Lou Y., Li Z. Risk factors for postoperative delirium after spine surgery in middle- and old-aged patients. Aging Clin Exp Res. 2017; 29(5): 1039-1044. DOI: 10.1007/s40520-016-0640-4. PMID: 27766513

29. Oosthuizen D., Sturrock E.D. Exploring the impact of ACE inhibition in immunity and disease. J Renin Angiotensin Aldosterone Syst. 2022; 2022: 9028969. DOI:10.1155/2022/9028969. PMID: 36016727

30. Kheterpal S., Khodaparast O., Shanks A., O’Reilly M., Tremper K.K. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008; 22(2):180–186. DOI: 10.1053/j.jvca.2007.12.020. PMID: 18375317

31. Turan A., You J., Shiba A., Kurz A., Saager L., Sessler D.I. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg. 2012; 114(3): 552–560. DOI: 10.1213/ANE.0b013e318241f6af. PMID: 22253266

32. Railton C.J., Wolpin J., Lam-McCulloch J., Belo S.E. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth. 2010; 57(8): 736–744. DOI: 10.1007/s12630-010-9330-4. PMID: 20524103

33. Ishikawa S., Griesdale D.E.G., Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg. 2012; 114(6): 1256–1262. DOI: 10.1213/ANE.0b013e31824e2d20. PMID: 22451594

34. Nielson E., Hennrikus E., Lehman E., Mets B. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery. J Hosp Med. 2014; 9(5): 283–288. DOI: 10.1002/jhm.2155. PMID: 24464761

35. Zabolotskikh I.B., Trembach N.V., Magomedov M.A., Krasnov V.G., Cherniyenko L.Yu., Shevyrev S.N., Popov A.S,.et al. Possibilities of preoperative assessment of the risk of an adverse outcome after abdominal surgery: preliminary results of the multicenter STOPRISK study. Ann Crit Care /Vestnik Intensivnoy Terapii im AI Saltanova. 2020; (4): 12–27 (in Russ.) DOI:10.21320/1818-474X-2020-4-12-27.